Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

AIG1 Inhibitors

Chemical inhibitors of AIG1 can impact its activity through various mechanisms, primarily by disrupting the signaling pathways and cellular processes it is involved in. Staurosporine, as a broad-spectrum protein kinase inhibitor, can impede the phosphorylation events necessary for AIG1's activity, thereby leading to its functional inhibition. Similarly, LY294002 and Wortmannin, both phosphoinositide 3-kinase (PI3K) inhibitors, can disrupt the PI3K signaling cascade. This disruption can cause a decrease in downstream signaling events that AIG1 may rely upon for its activity within the cell. U0126 and PD98059, both inhibitors of MEK, target the MAPK/ERK pathway; this inhibition leads to a reduction in ERK activation, which is a pathway that can be crucial for the functional role of AIG1. SB203580 focuses on inhibiting p38 MAPK, affecting the stress response pathways that are another potential aspect of AIG1's role in cellular responses.

In addition to these, PF-4708671 and Rapamycin target components of the mTOR pathway, with PF-4708671 specifically inhibiting p70S6 Kinase and Rapamycin targeting mTOR itself. The inhibition of these kinases can lead to a decrease in cellular growth and proliferation signals, which AIG1 is suggested to be associated with. SP600125, a c-Jun N-terminal kinase (JNK) inhibitor, can alter the stress and inflammation response, potentially affecting AIG1's function in these processes. On the other hand, proteasome inhibitors such as MG132 and Bortezomib can induce the accumulation of proteins within the cell, which can indirectly affect AIG1's function by disrupting the protein turnover processes that are essential for its regular activity. Lastly, Lestaurtinib, a tyrosine kinase inhibitor, impedes various tyrosine kinase-related signaling pathways, which AIG1 may depend on for its proper function within the cell. The collective action of these inhibitors can lead to a broad inhibition of AIG1's function by affecting the phosphorylation, signaling pathways, and protein turnover processes it is involved in.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lestaurtinib

111358-88-4sc-218657
sc-218657A
sc-218657B
1 mg
5 mg
10 mg
$275.00
$326.00
$612.00
3
(1)

Lestaurtinib is a tyrosine kinase inhibitor. By inhibiting tyrosine kinases, it can interrupt signaling pathways that AIG1 relies on for its function, thereby inhibiting AIG1 activity.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib is a proteasome inhibitor. It can lead to the accumulation of ubiquitinated proteins, which may indirectly inhibit AIG1 by disrupting the proteostasis that AIG1 relies on for its function.